In one more study, Riluzole-loaded NLCs were formulated and functionalized with lactoferrin (Lf), which improved conveyance within the BBB by interacting with Lf receptors in the endothelium of the brain to treat the neurodegenerative disease Amyotrophic lateral sclerosis. The gene discussed is LTF; the disease is amyotrophic lateral sclerosis.